GLP-3 RTA vs NAD+
GLP-3 RTA and NAD+ come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do GLP-3 RTA and NAD+ differ?
GLP-3 RTA (Synthetic triple-agonist peptide) is catalogued under weight & metabolic research; NAD+ (Nicotinamide adenine dinucleotide · cellular-metabolism research) is catalogued under longevity & cellular research. Verve lists 5 reported research applications for GLP-3 RTA and 5 for NAD+. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | GLP-3 RTA | NAD+ |
|---|---|---|
| compound class | Synthetic triple-agonist peptide | Nicotinamide adenine dinucleotide · cellular-metabolism research |
| research area | weight & metabolic | longevity & cellular |
| reported research applications | 5 listed | 5 listed |
| supplied as | single compound | single compound |
| catalog sizes | 10mg · 20mg · 30mg | 1000mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $142.99 | $78.99 |
| availability | in stock | in stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is GLP-3 RTA and what is NAD+?
GLP-3 RTA is classified as Synthetic triple-agonist peptide; NAD+ as Nicotinamide adenine dinucleotide · cellular-metabolism research. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
GLP-3 RTA
Synthetic triple-agonist peptide
GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.
full GLP-3 RTA profile →NAD+
Nicotinamide adenine dinucleotide · cellular-metabolism research
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell and central to redox reactions and cellular energy metabolism. Verve's NAD+ is a high-purity research preparation supplied for the laboratory study of cellular energetics and redox biology.
full NAD+ profile →Which research models is each compound studied in?
GLP-3 RTA sits in weight & metabolic research and NAD+ in longevity & cellular research, so their listed models largely do not intersect. The table lists 5 reported research applications for GLP-3 RTA and 5 for NAD+. Rows are per compound, not equivalences.
| GLP-3 RTA — reported research applications | NAD+ — reported research applications |
|---|---|
| GLP-1, GIP, and glucagon receptor agonism research | Cellular energy-metabolism research |
| cAMP and class B GPCR signaling research models | Sirtuin and PARP enzyme research |
| Comparative single-, dual-, and triple-agonist pharmacology studies | Mitochondrial-function research models |
| Metabolic-pathway and nutrient-handling research models | Redox-biology (NAD+/NADH ratio) research |
| Peptide half-life, lipidation, and stability research | Longevity and cellular-aging research models |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for GLP-3 RTA and NAD+?
GLP-3 RTA is listed from $142.99 and NAD+ from $78.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| GLP-3 RTA | 10mg | $142.99 | in stock |
| GLP-3 RTA | 20mg | $242.99 | in stock |
| GLP-3 RTA | 30mg | $328.99 | in stock |
| NAD+ | 1000mg | $78.99 | in stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about GLP-3 RTA and NAD+
What is GLP-3 RTA?
GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is GLP-3 RTA studied for in research?
In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.
What is NAD+?
NAD+ is nicotinamide adenine dinucleotide, a coenzyme central to redox reactions and energy metabolism in cells. Verve supplies a high-purity research preparation for laboratory use only.
What is NAD+ studied for in research?
It is used in research on cellular energy metabolism, sirtuin and PARP enzyme activity, mitochondrial function, and DNA-repair pathways. It is not for human or veterinary use.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.